Echocardiography

In this series, we dive into what rheumatologists should know about pulmonary hypertension, starting an interview with Joseph Parambil, MD, where we learn about the disease, when to suspect and how to work up!

BOSTON — A multimodal fusion model outperformed transthoracic echocardiography in identifying pulmonary hypertension, according to a study presented at the CHEST Annual Meeting.

BOSTON — Among patients with interstitial lung disease, 30% had pulmonary arterial hypertension and 20% had right ventricular hypertrophy, according to data presented at the CHEST Annual Meeting.

AISAP announced the FDA granted 510(k) clearance for its first-in-class, AI-powered point-of-care ultrasound software platform for the measurement of several cardiac pathologies.

Explanations of echocardiography findings written using ChatGPT may be suitable to educate patients about their health status and reduce physician workload, according to data published in JACC: Cardiovascular Imaging.

Lantheus Holdings announced the FDA has approved the supplemental new drug application for its perflutren lipid microsphere injection to improve ultrasound imaging in pediatric patients with suboptimal echocardiograms.

Philips announced it received FDA 510(k) clearance of its next-generation, miniaturized, transesophageal echocardiography transducer which can be used in very small patients and complex ICU cases.

Congenital heart defects are the most common type of birth defect, affecting nearly 1% of births per year in the United States, according to the CDC.

Artificial intelligence decision support vs. sonographer on timing and accuracy of assessment of echocardiograms.

Intracardiac echocardiography use during ablation for atrial fibrillation reduced readmissions at 90 days by 12%, driven by a 24% decrease in HF‐related admissions, researchers reported.